Patent Assignment
Reel/Frame 025114/0848
Security Interest
Recorded: 2010-10-08
Pages: 30
Assignor
VICTORY PHARMA, INC.
Executed: 2010-07-29
Assignee
BANK OF AMERICA, N.A.
315 MONTGOMERY STREET, 13TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94104
Covered Properties
(42)
Antifungal Product, Use and Formulation Thereof
Application:
10/292,617 →
Publication:
US US20030099707A1
Antibiotic product, use and formulation thereof
Application:
10/611,076 →
Publication:
US US20040052842A1
Modified release amoxicillin products
Modified release dosage forms of amoxicillin
Application:
11/634,633 →
Publication:
US US20080139526A1
Antibiotic product, use and formulation thereof
Antibiotic Product, Use and Formulation Thereof
Antibiotic Product, Use and Formulation Thereof
Robust pellet
Antibiotic Product, Use and Formulation Thereof
Antibiotic Product, Use and Formulation Thereof
Antibiotic product, use and formulation thereof
Enhanced absorption of modified release dosage forms
Application:
11/021,309 →
Publication:
US US20050142187A1
Tablet for Pulsed Delivery
Compositions and Methods for Improved Efficacy of Penicillin-Type Antibiotics
Gastric Release Pulse System for Drug Delivery
Pharmaceutical Compositions and Methods for Improved Bacterial Eradication
Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus
Application:
11/890,747 →
Publication:
US US20100016333A1
Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus
Application:
12/459,415 →
Publication:
US US20100120896A1
Antibiotic Product, Use and Formulation Thereof
Antibiotic Composition
Anti-Fungal Composition
Antiviral Product, Use and Formulation Thereof
Antibiotic Product, Use and Formulation Thereof
Levofloxacin Antibiotic Product, Use and Formulation Thereof
Antibiotic Product, Use and Formulation Thereof
Fluroquinilone Antibiotic Product, Use and Formulation Thereof
Metronidazole Antibiotic Product, Use and Formulation Thereof
Tetracycline Antibiotic Product, Use and Formulation Thereof
Erythromyacin Antibiotic Product, Use and Formulation Thereof
Cephalosporin-Metronidazole Antibiotic Composition
Amoxicillin-Dicloxacillin Antibiotic Composition
Ciprofoxacin-Metronidazole Antibiotic Composition
Tetracycline - Doxycycline Antibiotic Composition
Amoxicillin - Clarithromycin Antibiotic Composition
Multiple-Delayed Release Antibiotic Product, Use and Formulation Thereof
Multiple-Delayed Release Antifungal Product, Use and Formulation Thereof
Multiple-Delayed Release Anti-Viral Product, Use and Formulation Thereof
Antiviral Product, Use and Formulation Thereof
Antiviral Product, Use and Formulation Thereof
Antibiotic Composition
Antibiotic Composition with Inhibitor
Antibiotic Composition with Inhibitor
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 22, 2004
From: CAO, BRUCE X.; BURNSIDE, BETH A.; WASSINK, SANDRA E.; BAKER, MATT R.
To: ADVANCIS PHARMACEUTICALS CORPORATION
Reel/Frame 015164/0160 →
Change of Name
Nov 9, 2007
From: ADVANCIS PHARMACEUTICAL CORPORATION
To: MIDDLEBROOK PHARMACEUTICALS, INC.
Reel/Frame 020089/0910 →
Assignment of Assignor's Interest
Sep 9, 2010
From: MIDDLEBROOK PHARMACEUTICALS, INC.
To: VICTORY PHARMA, INC.
Reel/Frame 024964/0036 →
Security Agreement
Jul 29, 2011
From: BANK OF AMERICA, N.A.
To: VICTORY PHARMA, INC.
Reel/Frame 026676/0070 →
Assignment of Assignor's Interest
Oct 3, 2011
From: VICTORY PHARMA, INC.
To: SHIONOGI INC.
Reel/Frame 027004/0189 →